B cells from patients with common variable panhypogammaglobulinemia are intrinsically unable to mature to high-rate antibody-secreting cells at the normal pace even in the presence of normal interacting T cells and monocytes. However, they are able to perform certain early and intermediate activation events normally, so failure to become activated appears not to be their problem. Anticipating that identifying the defective step in B cells from different patients will reveal much about normal B cell activation, we propose to exploit recently described alternative modes of activating B cells with factors or reagents that act with or after surface Ig crosslinking to promote progression to DNA-synthesis or antibody secretion. These experiments should distinguish patients with defective differentiation from patients with defective proliferation. A potentially important new approach is to analyze how cytochalasins, which prevent actin assembly into microfilaments, promote advancement to DNA synthesis, and whether they can do so in patients whose normal mechanisms are blocked. Finally, using a variety of assays for early biochemical and cell surface events in activation, we will discover whether the differentiation factor interferon beta 2, the high and low molecular weight B cell growth factors, and anti-CDw40, utilize any of the known signal transduction pathways or stimulate intermediate events, so we can also determine how far their signals progress in defective B cells. This approach has the dual objective of elucidating normal B cell differentiation and proliferation signals at the biochemical level, and also understanding the physiology of the defective B cells, eventually leading to new strategies for regulation of antibody production.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM036261-07
Application #
3289859
Study Section
Immunological Sciences Study Section (IMS)
Project Start
1985-07-01
Project End
1993-06-30
Budget Start
1988-07-01
Budget End
1989-06-30
Support Year
7
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Iowa
Department
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Mower Jr, D A; Peckham, D W; Illera, V A et al. (1994) Decreased membrane phospholipid packing and decreased cell size precede DNA cleavage in mature mouse B cell apoptosis. J Immunol 152:4832-42
Molitor, J; Pace, W; Stunz, L et al. (1994) Induction of ornithine decarboxylase activity in mouse B lymphocytes. Int Immunol 6:1777-84
Illera, V A; Perandones, C E; Stunz, L L et al. (1993) Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4. J Immunol 151:2965-73
Peckham, D W; Mower Jr, D A; Ashman, R F (1993) Analysis of high and low responses to Staphylococcus aureus and interleukin 2 in human B lymphocytes. J Clin Immunol 13:424-38
Perandones, C E; Illera, V A; Peckham, D et al. (1993) Regulation of apoptosis in vitro in mature murine spleen T cells. J Immunol 151:3521-9
Ashman, R F; Schaffer, F M; Kemp, J D et al. (1992) Genetic and immunologic analysis of a family containing five patients with common-variable immune deficiency or selective IgA deficiency. J Clin Immunol 12:406-14
Yokoyama, W M; Chien, M M; Engardt, S E et al. (1988) Membrane depolarization of human B cells follows stimulation by either anti-mu or B-cell growth factor, but only anti-mu causes cell volume changes. Hum Immunol 21:155-64
Chien, M M; Yokoyama, W M; Ashman, R F (1986) Mitogen-stimulated phospholipid synthesis in normal and immune-deficient human B cells. J Immunol 136:2844-50